ABVC BioPharma
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $389 | $117 | $1 | $2 |
Gross Profit | 388 | 116 | -144 | |
EBITDA | 92 | -1,110 | -3,295 | -2,043 |
EBIT | 85 | -1,123 | -3,296 | -2,051 |
Net Income | -186 | -1,012 | -3,932 | -3,110 |
Net Change In Cash | 389 | 117 | 1 | 2 |
Free Cash Flow | 171 | -1,014 | -602 | -440 |
Cash | 137 | 124 | 659 | 716 |
Basic Shares | 12,405 | 11,321 | 9,736 | 7,940 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $152 | $969 | $355 | $483 |
Gross Profit | -149 | 683 | 350 | 464 |
EBITDA | -8,132 | -15,196 | -10,971 | -10,371 |
EBIT | -8,160 | -15,220 | -10,983 | -10,408 |
Net Income | -10,515 | -16,312 | -12,035 | -10,593 |
Net Change In Cash | 152 | 969 | 355 | 483 |
Free Cash Flow | -4,257 | -7,518 | -7,615 | -4,563 |
Cash | 60 | 85 | 5,828 | 4,273 |
Basic Shares | 4,335 | 3,166 | 2,505 | 1,971 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.01 |
2024-06-30 | -$0.08 |
2024-03-31 | -$0.40 |
2023-12-31 | -$0.39 |
